Literature DB >> 20080732

Penetrating cation/fatty acid anion pair as a mitochondria-targeted protonophore.

Fedor F Severin1, Inna I Severina, Yury N Antonenko, Tatiana I Rokitskaya, Dmitry A Cherepanov, Elena N Mokhova, Mikhail Yu Vyssokikh, Antonina V Pustovidko, Olga V Markova, Lev S Yaguzhinsky, Galina A Korshunova, Nataliya V Sumbatyan, Maxim V Skulachev, Vladimir P Skulachev.   

Abstract

A unique phenomenon of mitochondria-targeted protonophores is described. It consists in a transmembrane H(+)-conducting fatty acid cycling mediated by penetrating cations such as 10-(6'-plastoquinonyl)decyltriphenylphosphonium (SkQ1) or dodecyltriphenylphosphonium (C(12)TPP). The phenomenon has been modeled by molecular dynamics and directly proved by experiments on bilayer planar phospholipid membrane, liposomes, isolated mitochondria, and yeast cells. In bilayer planar phospholipid membrane, the concerted action of penetrating cations and fatty acids is found to result in conversion of a pH gradient (DeltapH) to a membrane potential (Deltapsi) of the Nernstian value (about 60 mV Deltapsi at DeltapH = 1). A hydrophobic cation with localized charge (cetyltrimethylammonium) failed to substitute for hydrophobic cations with delocalized charge. In isolated mitochondria, SkQ1 and C(12)TPP, but not cetyltrimethylammonium, potentiated fatty acid-induced (i) uncoupling of respiration and phosphorylation, and (ii) inhibition of H(2)O(2) formation. In intact yeast cells, C(12)TPP stimulated respiration regardless of the extracellular pH value, whereas a nontargeted protonophorous uncoupler (trifluoromethoxycarbonylcyanide phenylhydrazone) stimulated respiration at pH 5 but not at pH 3. Hydrophobic penetrating cations might be promising to treat obesity, senescence, and some kinds of cancer that require mitochondrial hyperpolarization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20080732      PMCID: PMC2818959          DOI: 10.1073/pnas.0910216107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity.

Authors:  Camille C Caldeira da Silva; Fernanda M Cerqueira; Lívea F Barbosa; Marisa H G Medeiros; Alicia J Kowaltowski
Journal:  Aging Cell       Date:  2008-07-10       Impact factor: 9.304

Review 2.  Programmed and altruistic ageing.

Authors:  Valter D Longo; Joshua Mitteldorf; Vladimir P Skulachev
Journal:  Nat Rev Genet       Date:  2005-11       Impact factor: 53.242

3.  Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria.

Authors:  Yunxia O'Malley; Brian D Fink; Nicolette C Ross; Thomas E Prisinzano; William I Sivitz
Journal:  J Biol Chem       Date:  2006-10-23       Impact factor: 5.157

4.  3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats.

Authors:  Antonia Lanni; Maria Moreno; Assunta Lombardi; Pieter de Lange; Elena Silvestri; Maurizio Ragni; Paola Farina; Gabriella Chieffi Baccari; Pupah Fallahi; Alessandro Antonelli; Fernando Goglia
Journal:  FASEB J       Date:  2005-07-12       Impact factor: 5.191

5.  Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools.

Authors:  Andrew M James; Helena M Cochemé; Robin A J Smith; Michael P Murphy
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

6.  Fatty acid flip-flop in a model membrane is faster than desorption into the aqueous phase.

Authors:  Jeffrey R Simard; Biju K Pillai; James A Hamilton
Journal:  Biochemistry       Date:  2008-08-12       Impact factor: 3.162

7.  Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis.

Authors:  Abdulrahman K Doughan; Sergey I Dikalov
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

8.  Kinetic analysis of permeation of mitochondria-targeted antioxidants across bilayer lipid membranes.

Authors:  Tatyana I Rokitskaya; Sergey S Klishin; Inna I Severina; Vladimir P Skulachev; Yuri N Antonenko
Journal:  J Membr Biol       Date:  2008-09-20       Impact factor: 1.843

Review 9.  Targeting antioxidants to mitochondria by conjugation to lipophilic cations.

Authors:  Michael P Murphy; Robin A J Smith
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

10.  Targeting dinitrophenol to mitochondria: limitations to the development of a self-limiting mitochondrial protonophore.

Authors:  Frances H Blaikie; Stephanie E Brown; Linda M Samuelsson; Martin D Brand; Robin A J Smith; Michael P Murphy
Journal:  Biosci Rep       Date:  2006-06       Impact factor: 3.840

View more
  44 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 2.  Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.

Authors:  Nadezda Apostolova; Victor M Victor
Journal:  Antioxid Redox Signal       Date:  2015-03-10       Impact factor: 8.401

3.  Mitochondria targeting of non-peroxidizable triphenylphosphonium conjugated oleic acid protects mouse embryonic cells against apoptosis: role of cardiolipin remodeling.

Authors:  Yulia Y Tyurina; Muhammad A Tungekar; Mi-Yeon Jung; Vladimir A Tyurin; Joel S Greenberger; Detcho A Stoyanovsky; Valerian E Kagan
Journal:  FEBS Lett       Date:  2011-12-28       Impact factor: 4.124

Review 4.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

5.  Accumulation of dodecyltriphenylphosphonium in mitochondria induces their swelling and ROS-dependent growth inhibition in yeast.

Authors:  Silvia M Ojovan; Dmitry A Knorre; Olga V Markova; Ekaterina A Smirnova; Lora E Bakeeva; Fedor F Severin
Journal:  J Bioenerg Biomembr       Date:  2011-03-01       Impact factor: 2.945

6.  Limited perturbation of a DPPC bilayer by fluorescent lipid probes: a molecular dynamics study.

Authors:  David G Ackerman; Frederick A Heberle; Gerald W Feigenson
Journal:  J Phys Chem B       Date:  2013-04-19       Impact factor: 2.991

7.  Derivatives of rhodamine 19 as mild mitochondria-targeted cationic uncouplers.

Authors:  Yuri N Antonenko; Armine V Avetisyan; Dmitry A Cherepanov; Dmitry A Knorre; Galina A Korshunova; Olga V Markova; Silvia M Ojovan; Irina V Perevoshchikova; Antonina V Pustovidko; Tatyana I Rokitskaya; Inna I Severina; Ruben A Simonyan; Ekaterina A Smirnova; Alexander A Sobko; Natalia V Sumbatyan; Fedor F Severin; Vladimir P Skulachev
Journal:  J Biol Chem       Date:  2011-03-30       Impact factor: 5.157

Review 8.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

9.  Induction of autophagy by depolarization of mitochondria.

Authors:  Konstantin G Lyamzaev; Artem V Tokarchuk; Alisa A Panteleeva; Armen Y Mulkidjanian; Vladimir P Skulachev; Boris V Chernyak
Journal:  Autophagy       Date:  2018-03-13       Impact factor: 16.016

Review 10.  Evolution of cytochrome bc complexes: from membrane-anchored dehydrogenases of ancient bacteria to triggers of apoptosis in vertebrates.

Authors:  Daria V Dibrova; Dmitry A Cherepanov; Michael Y Galperin; Vladimir P Skulachev; Armen Y Mulkidjanian
Journal:  Biochim Biophys Acta       Date:  2013-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.